Researchers have developed a GPS vaccine that guides the immune system to create broadly neutralizing antibodies against HIV. For many years, researchers have been trying to develop an HIV vaccine ...

Rice University bioengineer Omid Veiseh has been awarded a $2.2 million grant from the Gates Foundation to develop implantable cell factory platforms that can deliver therapeutic antibodies over ...

A study has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes ...

An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. This study, led by ...

LA JOLLA, CA and NEW YORK, NY—A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of ...

An HIV vaccine candidate developed at the Duke Human Vaccine Institute (DHVI) triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a ...

Antibodies are small proteins that are secreted by specialized cells to target and neutralize pathogens. The “Y” shaped structure is crucial for active immunity and work by binding and tagging ...

Discovery brings us one step closer to vaccine and treatment for prevalent virus. Image courtesy of the Centers for Disease Control. Scientists at The University of Texas at Austin, in collaboration ...